Atrial Fibrillation With Modern Cancer Treatment: More Common Than We Think
JACC CardioOncol
.
2023 Apr 18;5(2):227-229.
doi: 10.1016/j.jaccao.2023.03.006.
eCollection 2023 Apr.
Authors
Daniel Addison
1
2
,
Cooper Quartermaine
1
,
Jonathan E Brammer
3
Affiliations
1
Cardio-Oncology Program, Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
2
Division of Cancer Prevention and Control, The Ohio State University, Columbus, Ohio, USA.
3
Division of Hematology, The Ohio State University Medical Center, Columbus, Ohio, USA.
PMID:
37144114
PMCID:
PMC10152195
DOI:
10.1016/j.jaccao.2023.03.006
No abstract available
Keywords:
BTK inhibitors; atrial fibrillation; cardio-oncology; cardiotoxicity; clinical trials.
Publication types
Editorial
Grants and funding
K23 HL155890/HL/NHLBI NIH HHS/United States
L30 HL149063/HL/NHLBI NIH HHS/United States